This paper is in the following e-collection/theme issue:

Wearables and MHealth Reviews (276) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1428) mHealth for Telemedicine and Homecare (418) Stroke (166) Hypertension Prevention and Treatment (229) Telehealth and Telemonitoring (1713) e-Cardiology and Telemonitoring in Cardiology (172)

Published on in Vol 9, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/24116, first published .
Effects of Telemedicine and mHealth on Systolic Blood Pressure Management in Stroke Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of Telemedicine and mHealth on Systolic Blood Pressure Management in Stroke Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of Telemedicine and mHealth on Systolic Blood Pressure Management in Stroke Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Authors of this article:

Meina Lv1 Author Orcid Image ;   Tingting Wu1 Author Orcid Image ;   Shaojun Jiang1 Author Orcid Image ;   Wenjun Chen1 Author Orcid Image ;   Jinhua Zhang1 Author Orcid Image
Article Authors Cited by (21) Tweetations (13) Metrics

    Review

    Department of Pharmacy, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, China

    *these authors contributed equally

    Corresponding Author:

    Jinhua Zhang, PhD

    Department of Pharmacy

    Fujian Medical University Union Hospital

    Fujian Medical University

    29 Xinquan Road

    Fuzhou, 350001

    China

    Phone: 86 591 83357896 ext 8301

    Fax:86 591 83357896

    Email: pollyzhang2006@126.com


    Background: Stroke is a common, harmful disease with high recurrence and mortality rates. Uncontrolled blood pressure is an important and changeable risk factor for stroke recurrence. Telemedicine and mobile health (mHealth) interventions may have the potential to facilitate the control of blood pressure among stroke survivors, but their effect has not been established.

    Objective: This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to estimate the effects of telemedicine and mHealth interventions on the control of systolic blood pressure among stroke survivors.

    Methods: The research literature published up to June 28, 2020, and consisting of RCTs related to telemedicine and mHealth interventions was searched in PubMed, EMBASE, Web of Science, and the Cochrane Library. The Cochrane risk of bias tool (RoB 2.0) was used to evaluate the quality of the studies. The Cochran Q test and I2 statistic were used to assess heterogeneity. Data were meta-analyzed using a random-effects model. Mean difference (MD) with 95% CI and 95% prediction interval (PI) were calculated.

    Results: In total, 9 RCTs with a total sample size of 1583 stroke survivors met the inclusion criteria. Compared with the usual care, telemedicine and mHealth had a significantly greater impact on the control of systolic blood pressure (MD –5.49; 95% CI –7.87 to –3.10; P<.001; 95% PI –10.46 to –0.51). A subgroup analysis showed that the intervention mode of telephone plus SMS text messaging (MD –9.09; 95% CI –12.71 to –5.46; P<.001) or only telephone (MD –4.34; 95% CI –6.55 to –2.13; P<.001; 95% PI –7.24 to –1.45) had a greater impact on the control of systolic blood pressure than usual care. Among the stroke survivors with an intervention interval ≤1 week (MD –6.51; 95% CI –9.36 to –3.66; P<.001; 95% PI –12.91 to –0.10) or a baseline systolic blood pressure ≥140 mm Hg (MD –6.15; 95% CI –9.44 to –2.86; P<.001; 95% PI –13.55 to 1.26), the control of systolic blood pressure using telemedicine and mHealth was better than that of usual care.

    Conclusions: In general, telemedicine and mHealth reduced the systolic blood pressure of stroke survivors by an average of 5.49 mm Hg compared with usual care. Telemedicine and mHealth are a relatively new intervention mode with potential applications for the control of systolic blood pressure among stroke survivors, especially those with hypertensive stroke.

    JMIR Mhealth Uhealth 2021;9(6):e24116

    doi:10.2196/24116

    Keywords

    stroke; systolic blood pressure; mHealth; telemedicine; meta-analysis; self-management 


    Stroke is a common, harmful disease and a main cause of death and disability worldwide. It has the characteristics of high morbidity, disability, recurrence, and mortality [1-3]. Stroke survivors have a high risk of recurrence, with recurrent stroke entailing more severe symptoms and worse results than the first occurrence [4,5]. Stroke not only affects patients’ quality of life but also imposes an economic burden on the family, medical system, and society [6,7]. However, about 85% of stroke cases are preventable, and effective secondary prevention can reduce the recurrence rate of stroke [8-10].

    Noncommunicable diseases are the main causes for the increase in the incidence of stroke. Approximately 90.5% of global stroke diseases can be attributed to modifiable risk factors, among which hypertension is the most common for first and recurrent strokes but is modifiable [11-13]. Uncontrolled blood pressure is an important changeable risk factor for stroke recurrence. Implementing secondary preventive measures can reduce the recurrence of stroke by 80% [14]. A recent systematic review and meta-regression analysis emphasized that strict and active blood pressure control may be the most critical treatment strategy for the secondary prevention of stroke, highlighting that the reduction in systolic blood pressure is linearly related to reduction in the risk of recurrent cerebrovascular events [15]. However, many stroke survivors have the risk factor of high blood pressure [14]. More than one-third of patients continue to have poor blood pressure control following a stroke or transient ischemic attack, but most people are unaware of these risks [14,16].

    Therefore, some researchers have tried to reduce the risk of recurrent cerebrovascular events through interventions to improve blood pressure after a stroke or transient ischemic attack. Telemedicine and mobile health (mHealth) interventions have a potential role in this endeavor. An increasing number of studies have been conducted on the use of telemedicine and mHealth interventions to manage systolic blood pressure in stroke survivors [17-25], but it is not clear whether their effect is better than that of usual care. To objectively evaluate the efficacy of these interventions and provide a reference for clinical application, this study adopted the Cochrane evaluation method to conduct a systematic review and meta-analysis of existing international randomized controlled trials (RCTs) related to telemedicine and mHealth for control of systolic blood pressure in stroke survivors.


    Data Sources and Search Strategy

    This study follows the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [26]. We conducted a comprehensive literature search in online databases, including PubMed, EMBASE, Web of Science, and the Cochrane Library. In order to conduct a comprehensive search, we also searched Chinese literature, gray literature, and the reference lists of the studies yielded by the original search. We searched relevant studies published until June 28, 2020. The search keywords were as follows: “stroke” OR “brain infarction” OR “transient ischemic attack” OR “cerebral hemorrhage” OR “subarachnoid hemorrhage,” “mobile applications” OR “telemedicine” OR “text messaging” OR “cell phone” OR “smartphone” OR “social media” OR “internet,” and “blood pressure” OR “hypertension.” A detailed search strategy for each database is presented in Multimedia Appendix 1. The literature search and screening were carried out independently by 2 researchers (ML and TW).

    Inclusion Criteria

    We included all studies that met the following requirements: the study’s design was an RCT, participants were diagnosed with a stroke (hemorrhagic stroke or ischemic stroke) or transient ischemic attack, interventions were provided for patients using telemedicine (with telemedicine defined as the provision of health services at a distance using a range of technologies, such as telephone, telemonitoring, etc [27,28]) and mHealth (with mHealth defined as the delivery of health service through mobile and wireless applications, including mobile phones, SMS text messaging, wearable devices, etc [29]), the control group received usual care, and the main outcome indicator was systolic blood pressure.

    Exclusion Criteria

    Studies were excluded from the meta-analysis if any of the telemedicine and mHealth intervention or usual care management was independently discussed, or if the original research data were incomplete or unusable and useful data could not be obtained by contacting the original author.

    Data Extraction

    The data were retrieved from the selected studies. The extracted data included study information (author, publication year, country), study characteristics (study population, sample size), participants’ characteristics (age, gender, baseline systolic blood pressure), intervention information (intervention mode, intervention interval), and main outcome indicators (systolic blood pressure). The required data were extracted independently by 2 researchers (ML and TW) and cross-referenced to avoid potential extraction errors. All disagreements were discussed with a third researcher to reach a consensus.

    Quality Assessment

    Two independent researchers used the Cochrane risk of bias tool (RoB 2.0) [30] to evaluate the quality of the selected literature. The items addressed were as follows: bias arising from the randomization process, deviations from intended interventions, bias due to missing outcome data, bias in measurement of the outcome, bias in the selection of the reported result, and overall risk of bias. An additional researcher was asked to conduct an evaluation to help resolve disputes that arose during the evaluation process.

    Statistical Analysis

    Stata version 14.0 (StataCorp) was used for the meta-analysis. The Cochran Q test and I2 statistic were used to assess heterogeneity [31]. In the heterogeneity assessment, I2 is considered to be nil if it is below 25%, low if it is 25%-50%, moderate if it is 51%-75%, and high if it is above 75% [32]. Due to expected heterogeneity (study characteristics and the manner in which studies were conducted) between studies, a random-effects model was used to estimate the mean difference (MD) with 95% CI being considered the statistic of interest [33]. In addition, the 95% prediction interval (PI) was calculated for the overall weighted mean estimate [34]. To explore the factors influencing mHealth interventions, we conducted subgroup analyses of the intervention mode, intervention interval, and baseline systolic blood pressure. Interrater agreement was calculated by using the κ statistic according to the following scheme: κ value <0, worse than that expected by chance; 0.21-0.40, poor; 0.41-0.60, moderate; 0.61-0.80, good; and 0.81-1.00, very good level of agreement [35]. Publication bias was evaluated by inspection of funnel plots and Egger tests [36]. In this study, a P value <.05 was considered statistically significant.


    Study Selection

    A total of 13,998 studies were retrieved using the search strategy. After screening, 9 studies were included in the meta-analysis, comprising a total of 1583 patients: 798 in the mHealth intervention group and 785 in the usual care group. The literature screening process and results are shown in Figure 1.

    ‎
    Figure 1. Flow diagram of the selection of studies. mHealth: mobile health; RCT: randomized controlled trial.
    View this figure

    Study Characteristics and Quality Assessment

    The basic characteristics of the included studies are presented in Multimedia Appendix 2. All of the included studies were RCTs and published in 2010 or later, which is in line with the rapid development and spread of mHealth technology in recent years. These studies were conducted in different countries and regions, of which 3 were from the United Kingdom [17-19], 2 from the United States [20,21], 2 from China [23,24], 1 from Ghana [22], and 1 from Sweden [25]. The participants were stroke survivors. The mean or median age of the patients ranged from 54.3 years to 73.5 years. The proportion of women ranged from 23.1% to 60.0%. We used the Cochrane risk of bias tool (RoB 2.0) to evaluate the risk of bias in the 9 included studies. The results showed that risk of bias was deemed to be either “low” or “with some concerns” (Table 1). A κ value of 0.768 (95% CI 0.673-0.841; P<.001) in this study indicated that there was a good agreement between encoders.

    Table 1. Cochrane risk-of-bias tool for randomized controlled trials (RoB 2.0).
    StudyBias arising from the randomization processDeviations from intended interventionsBias due to missing outcome dataBias in measurement of the outcomeBias in selection of the reported resultOverall risk of bias
    Adie et al (2010) [17]LowLowLowLowLowLowa
    Hanley et al (2015) [18]Some concernsSome concernsLowLowLowSome concernsb
    Kerry et al (2013) [19]LowLowLowLowLowLow
    Lakshminarayan et al (2018) [20]LowSome concernsLowLowLowSome concerns
    Mackenzie et al (2013) [21]LowSome concernsLowLowSome concernsSome concerns
    Sarfo et al (2018) [22]LowLowLowLowLowLow
    Wan et al (2018) [23]LowLowLowLowLowLow
    Wang et al (2020) [24]LowLowLowLowLowLow
    Ögren et al (2018) [25]LowSome concernsSome concernsLowLowSome concerns

    aLow: when present in this column, this indicates the study is judged to be at low risk of bias for all domains for this result.

    bSome concerns: when present in this column, the study is judged to raise some concerns in at least one domain for this result, but not due to a high risk of bias for any domain.

    Comparison of Changes in Systolic Blood Pressure

    Figure 2 [17-25] illustrates the changes in systolic blood pressure between the 2 groups in the 9 studies. There was statistical heterogeneity between studies (I2=23.7%). The results showed that the control of systolic blood pressure of the stroke survivors in the telemedicine and mHealth group was better than that of the stroke survivors in the usual care group, and the difference was statistically significant (MD –5.49; 95% CI –7.87 to –3.10; P<.001; 95% PI –10.46 to –0.51).

    ‎
    Figure 2. Forest plot of the systolic blood pressure of the telemedicine and mHealth group and usual care group. mHealth: mobile health; WMD: weighted mean difference.
    View this figure

    Subgroup Analyses

    We conducted subgroup analyses of the intervention mode. When the intervention mode consisted of telephone plus SMS text messaging or only telephone, the telemedicine and mHealth group showed a larger effect on the control of systolic blood pressure than did the usual care group, with an MD of –9.09 (95% CI –12.71 to –5.46; P<.001) and –4.34 (95% CI –6.55 to –2.13; P<.001; 95% PI –7.24 to –1.45), respectively (Figure 3 [17-25]).

    We also performed subgroup analyses of the intervention interval and baseline systolic blood pressure (Figures 4 and 5 [17-25]). Compared to the usual care group, the telemedicine and mHealth group had better control of systolic blood pressure, with an intervention interval ≤1 week, and the difference was statistically significant (MD –6.51; 95% CI –9.36 to –3.66; P<.001; 95% PI –12.91 to –0.10). When the intervention interval was greater than 1 week, no significant difference was found in the control of systolic blood pressure between the 2 groups (MD –2.08; 95% CI –10.12 to 5.95; P=.61; 95% PI –83.93 to 79.76). In addition, among the stroke survivors with a baseline systolic blood pressure <140 mm Hg, no significant difference in the control of systolic blood pressure was found between the mHealth intervention group and the usual care group (MD –4.04; 95% CI –8.75 to 0.67; P=.09; 95% PI –50.34 to 42.25). In contrast, among the stroke survivors with a baseline systolic blood pressure ≥140 mm Hg, the control of systolic blood pressure of the telemedicine and mHealth group was significantly better than that of the usual care group, and the difference was statistically significant (MD –6.15; 95% CI –9.44 to –2.86; P<.001; 95% PI –13.55 to 1.26).

    ‎
    Figure 3. Forest plot of the subgroup analysis of the mode of intervention. mHealth: mobile health; WMD: weighted mean difference.
    View this figure
    ‎
    Figure 4. Forest plot of the subgroup analysis of the intervention interval. mHealth: mobile health; WMD: weighted mean difference.
    View this figure
    ‎
    Figure 5. Forest plot of the subgroup analysis of the baseline systolic blood pressures. mHealth: mobile health; WMD: weighted mean difference.
    View this figure

    Publication Bias and Sensitivity Analysis

    Funnel plot inspection and the Egger test showed no publication bias (P=.16; Figure 6). Furthermore, a sensitivity analysis of the outcome indicators of systolic blood pressure was conducted using the method of excluding relevant studies one by one. The results did not change significantly, indicating that the findings of this analysis were stable.

    ‎
    Figure 6. Funnel plot of the systolic blood pressures. WMD: weighted mean difference.
    View this figure

    Stroke is characterized by high recurrence and mortality rates [1-3]. Hypertension is an important risk factor for stroke recurrence [13], so it is essential for stroke survivors to control their blood pressure. The main purpose of this meta-analysis was to evaluate the effect of telemedicine and mHealth interventions on the control of systolic blood pressure in stroke survivors. We conducted a systematic review and meta-analysis of 9 RCTs. Compared with usual care, the telemedicine and mHealth intervention reduced the systolic blood pressure by an average of 5.49 mm Hg. It is worth mentioning that this change in systolic blood pressure was equivalent to the decrease in the systolic blood pressure reported in a meta-analysis of interventions to improve the lifestyles of patients (eg, reasonable diet, aerobic exercise, restriction of alcohol and sodium intake) [37,38]. Studies have shown that a 3-mm Hg reduction in systolic blood pressure can reduce stroke mortality by 8% [39]. Therefore, telemedicine and mHealth interventions for stroke survivors may be a measure worth considering.

    As far as we know, this is the first systematic, quantitative analysis and summary of all available evidence of telemedicine and mHealth interventions for the management of systolic blood pressure in the population of stroke survivors. More importantly, we found that the stroke survivors in the telemedicine and mHealth group had better control of their systolic blood pressure than did the usual care group after receiving interventions that actively sent electronic messages (telephone calls, SMS text messages). This result may be expected because poor self-management and poor compliance are major problems affecting patients’ blood pressure control [40]. Stroke survivors with low compliance may benefit more from active interventions, such as telephone calls or SMS text messages. Therefore, active telemedicine and mHealth interventions may yield clinical benefits for stroke survivors by helping them achieve blood pressure control.

    This meta-analysis included RCTs from different countries (the United States, the United Kingdom, Sweden, Ghana, and China), indicating that mHealth interventions may be applicable to people in different countries and different medical systems. Furthermore, the average baseline systolic blood pressure was 128.0-154.0 mm Hg, which indicates that the included studies targeted stroke survivors extensively for telemedicine and mHealth interventions. We found that among the stroke survivors with a baseline systolic blood pressure <140 mm Hg, there was no significant difference between the telemedicine and mHealth group and the usual care group. However, for stroke survivors with a baseline systolic blood pressure ≥140 mm Hg, the telemedicine and mHealth group had significantly better control of systolic blood pressure than did the usual care group. This is a major finding in stroke survivors with a baseline systolic blood pressure ≥140 mm Hg, which indicates that telemedicine and mHealth interventions may have greater benefits for stroke survivors with hypertension. If the proper intervention is conducted for an extended period, this may have a significant clinical impact.

    Telemedicine and mHealth interventions are becoming an increasingly common way to support patients with chronic diseases in adhering to their medications and conducting self-management [41]. Telemedicine and mHealth interventions can provide reminder strategies and help patients achieve self-monitoring of blood pressure to improve their medical and behavioral management. Nursing staff can make personalized recommendations for blood pressure management based on patients’ feedback. We found that when the intervention interval was ≤1 week, the influence on the control of systolic blood pressure of the telemedicine and mHealth group was significantly greater than that of the usual care group. However, there was no significant difference between the 2 groups when the intervention interval was more than 1 week. These findings show that when implementing telemedicine and mHealth interventions for patients, the time interval should be at least 1 week in order to achieve a clinically meaningful effect on the control of systolic blood pressure.

    Our research has several limitations worth discussing. First, one of the main limitations is that the duration of the interventions included in the selected studies was relatively short. There was only 1 study over 12 months, and a lack of data from studies lasting more than 12 months makes it impossible to conduct subgroup analyses. Blood pressure control in stroke survivors may be a long-term process, requiring continuous lifestyle changes. It is important to understand the long-term (over 12 months) effectiveness and safety of telemedicine and mHealth interventions in stroke survivors. Thus, more research is needed for further analyses and verification. Second, compared with usual care, the telemedicine and mHealth intervention reduced the systolic blood pressure. Statistically speaking, the difference was significant, but its clinical significance still needs to be confirmed by further study. Third, as most of the included studies only provided limited information on the profiles of the participants, it was impossible to analyze the effects of some factors on the telemedicine and mHealth interventions, such as participants’ socioeconomic and educational status and combination of drugs, which still need to be explored further in future research.

    Preliminary analysis shows that the telemedicine and mHealth interventions reduced the systolic blood pressure of stroke survivors by 5.49 mm Hg on average compared with patients who received usual care. Telemedicine and mHealth interventions may be an important strategy to promote the control of systolic blood pressure in stroke survivors, and this benefit may be even greater for patients with hypertensive stroke. We also found that telemedicine and mHealth interventions with active reminders via telephone calls or SMS text messages and an intervention interval ≤1 week may be more effective. In short, telemedicine and mHealth interventions are relatively new. If used correctly, they have potential application in the control of systolic blood pressure in stroke survivors, specifically those with hypertensive stroke.

    Acknowledgments

    This study was funded by the Natural Science Foundation of Fujian Province of China (grant 2018Y0037) and the Fujian Medical Innovation Project of China (grant 2019-CX-19).

    Authors' Contributions

    JZ initiated the study. ML and TW performed the data extraction and analyses. ML drafted the first version of the manuscript. JZ and ML critically reviewed the manuscript and revised it. All authors made a substantial contribution to the concept and design of the study, interpreted the data, and reviewed the manuscript.

    Conflicts of Interest

    None declared.

    ‎
    Multimedia Appendix 1

    Search strategy.

    PDF File (Adobe PDF File), 72 KB
    ‎
    Multimedia Appendix 2

    Characteristics of the 9 randomized controlled trials included in the study.

    PDF File (Adobe PDF File), 67 KB
    1. Feigin VL, Mensah GA, Norrving B, Murray CJ, Roth GA. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study. Neuroepidemiology 2015:230-236 [FREE Full text] [CrossRef]
    2. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurology 2007 Feb;6(2):182-187 [FREE Full text] [CrossRef]
    3. Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurology 2007 Feb;6(2):94-97 [FREE Full text] [CrossRef]
    4. Leistner S, Michelson G, Laumeier I, Ahmadi M, Smyth M, Nieweler G. Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial. BMC Neurol 2013 Jan 24;13(1):1-8 [FREE Full text] [CrossRef]
    5. Zhang X, Pan J, Wan L, Liu Z, Mo M, Wang M. Factors influencing health behaviour, blood pressure control, and disability in hypertensive ischaemic stroke patients after a comprehensive reminder intervention. J Adv Nurs 2020;76(6):1384-1393 [FREE Full text] [CrossRef]
    6. Xu G, Liu X, Wu W, Zhang R, Yin Q. Recurrence after ischemic stroke in Chinese patients: impact of uncontrolled modifiable risk factors. Cerebrovasc Dis 2007;23(2-3):117-120 [FREE Full text] [CrossRef]
    7. Em S, Bozkurt M, Caglayan M, Ceylan Cevik F, Kaya C, Oktayoglu P. Psychological health of caregivers and association with functional status of stroke patients. Topics in Stroke Rehabilitation 2017;24(5):323-329 [FREE Full text] [CrossRef]
    8. Sarikaya H, Ferro J, Arnold M. Stroke prevention - medical and lifestyle measures. Eur Neurol 2015;73(3-4):150-157 [FREE Full text] [CrossRef]
    9. Jeon MY, Jeong H. Effects of a stroke primary prevention program on risk factors for at-home elderly. Med Sci Monit 2015;21:3696-3703 [FREE Full text] [CrossRef]
    10. Wang M, Shen M, Wan L, Mo M, Wu Z, Li L. Effects of a comprehensive reminder system based on the health belief model for patients who have had a stroke on health behaviors, blood pressure, disability, and recurrence from baseline to 6 months. The Journal of Cardiovascular Nursing 2020;35(2):156-164 [FREE Full text] [CrossRef]
    11. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, American Heart Association Stroke Council‚ Council on CardiovascularStroke Nursing‚ Council on Clinical Cardiology‚Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014 Jul;45(7):2160-2236. [CrossRef] [Medline]
    12. O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. The Lancet 2016 Aug;388(10046):761-775 [FREE Full text] [CrossRef]
    13. Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet Neurology 2016 Aug;15(9):913-924 [FREE Full text] [CrossRef]
    14. Doogue R, McCann D, Fitzgerald N, Murphy AW, Glynn LG, Hayes P. Blood pressure control in patients with a previous stroke/transient ischaemic attack in primary care in Ireland: a cross sectional study. BMC Fam Pract 2020 Jul 10;21(1):139-148 [FREE Full text] [CrossRef]
    15. Katsanos AH, Filippatou A, Manios E, Deftereos S, Parissis J, Frogoudaki A, et al. Blood pressure reduction and secondary stroke prevention. Hypertension 2017 Jan;69(1):171-179 [FREE Full text] [CrossRef]
    16. Alloubani A, Saleh A, Abdelhafiz I. Hypertension and diabetes mellitus as a predictive risk factors for stroke. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018 Jul;12(4):577-584 [FREE Full text] [CrossRef]
    17. Adie K, James MA. Does telephone follow-up improve blood pressure after minor stroke or TIA? Age and Ageing 2010 Jul 27;39(5):598-603 [FREE Full text] [CrossRef]
    18. Hanley J, Fairbrother P, Krishan A, McCloughan L, Padfield P, Paterson M, et al. Mixed methods feasibility study for a trial of blood pressure telemonitoring for people who have had stroke/transient ischaemic attack (TIA). Trials 2015 Mar 25;16(1):117-126 [FREE Full text] [CrossRef]
    19. Kerry SM, Markus HS, Khong TK, Cloud GC, Tulloch J, Coster D, et al. Home blood pressure monitoring with nurse-led telephone support among patients with hypertension and a history of stroke: a community-based randomized controlled trial. Canadian Medical Association Journal 2012 Nov 05;185(1):23-31 [FREE Full text] [CrossRef]
    20. Lakshminarayan K, Westberg S, Northuis C, Fuller CC, Ikramuddin F, Ezzeddine M, et al. A mHealth-based care model for improving hypertension control in stroke survivors: Pilot RCT. Contemporary Clinical Trials 2018 Jul;70:24-34 [FREE Full text] [CrossRef]
    21. Mackenzie G, Ireland S, Moore S, Heinz I, Johnson R, Oczkowski W. Tailored interventions to improve hypertension management after stroke or TIA--phase II (TIMS II). Can J Neurosci Nurs(1) 2013;35:27-34 [FREE Full text] [Medline]
    22. Sarfo F, Treiber F, Gebregziabher M, Adamu S, Patel S, Nichols M, et al. PINGS (Phone-Based Intervention Under Nurse Guidance After Stroke). Stroke 2018 Jan;49(1):236-239 [FREE Full text] [CrossRef]
    23. Wan L, Zhang X, You L, Ruan H, Chen S. The efficacy of a comprehensive reminder system to improve health behaviors and blood pressure control in hypertensive ischemic stroke patients. The Journal of Cardiovascular Nursing 2018;33(6):509-517 [FREE Full text] [CrossRef]
    24. Wang M, Shen M, Wan L, Mo M, Wu Z, Li L, et al. Effects of a comprehensive reminder system based on the health belief model for patients who have had a stroke on health behaviors, blood pressure, disability, and recurrence from baseline to 6 months. The Journal of Cardiovascular Nursing 2020;35(2):156-164 [FREE Full text] [CrossRef]
    25. Ögren J, Irewall A, Söderström L, Mooe T. Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial. BMC Neurol 2018 Sep 21;18(1):153-161 [FREE Full text] [CrossRef]
    26. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009 Jul 21;339:b2535 [FREE Full text] [CrossRef] [Medline]
    27. The Knowledge Network.   URL: http://www.knowledge.scot.nhs.uk/telehealthcare.aspx [accessed 2016-10-27]
    28. Ming W, Mackillop LH, Farmer AJ, Loerup L, Bartlett K, Levy JC, et al. Telemedicine technologies for diabetes in pregnancy: a systematic review and meta-analysis. J Med Internet Res 2016 Nov 09;18(11):e290 [FREE Full text] [CrossRef] [Medline]
    29. Borrelli B, Ritterband LM. Special issue on eHealth and mHealth: Challenges and future directions for assessment, treatment, and dissemination. Health Psychol 2015 Dec;34S:1205-1208. [CrossRef] [Medline]
    30. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019 Aug 28;366:l4898. [CrossRef] [Medline]
    31. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1. The Cochrane Collaboration.   URL: http://handbook-5-1.cochrane.org/ [accessed 2011-03-01]
    32. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 Sep 6;327(7414):557-560 [FREE Full text] [CrossRef] [Medline]
    33. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010 Apr;1(2):97-111. [CrossRef] [Medline]
    34. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Chichester: John Wiley & Sons; 2009.
    35. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 Mar;33(1):159. [CrossRef]
    36. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 Sep 13;315(7109):629-634 [FREE Full text] [CrossRef] [Medline]
    37. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006 Feb;24(2):215-233. [CrossRef] [Medline]
    38. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002 Apr 02;136(7):493-503. [CrossRef] [Medline]
    39. Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M. INTERSALT study findings. Public health and medical care implications. Hypertension 1989 Nov;14(5):570-577 [FREE Full text] [CrossRef]
    40. Amer M, Ur Rehman N, Nazir S, Ehsan-Ul-Haq M, Sultana M, Jabeen M. Devoid knowledge and low adherence precipitate uncontrolled blood pressure: a depiction from cross-sectional study. Altern Ther Health Med 2020 Jul 15;26(12). [Medline]
    41. Morrissey EC, Casey M, Glynn LG, Walsh JC, Molloy GJ. Smartphone apps for improving medication adherence in hypertension: patients' perspectives. Patient Prefer Adherence 2018;12:813-822 [FREE Full text] [CrossRef] [Medline]

    ‎
    MD: mean difference
    mHealth: mobile health
    PI: prediction interval
    PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
    RCT: randomized controlled trial

    Edited by L Buis; submitted 04.09.20; peer-reviewed by   Xiang, R Bajpai, KM Kuo; comments to author 21.12.20; revised version received 27.01.21; accepted 11.03.21; published 11.06.21

    Copyright

    ©Meina Lv, Tingting Wu, Shaojun Jiang, Wenjun Chen, Jinhua Zhang. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 11.06.2021.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.